The University of Chicago Header Logo

Connection

Derek Wainwright to Cell Line, Tumor

Back to Details
This is a "connection" page, showing publications Derek Wainwright has written about Cell Line, Tumor.
Derek Wainwright
Connection Strength
0.731
Cell Line, Tumor
  1. IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma. Clin Cancer Res. 2018 06 01; 24(11):2559-2573.
    View in: PubMed
    Score: 0.100
  2. Therapeutic Hypothesis Testing With Rodent Brain Tumor Models. Neurotherapeutics. 2017 04; 14(2):385-392.
    View in: PubMed
    Score: 0.093
  3. Advanced age negatively impacts survival in an experimental brain tumor model. Neurosci Lett. 2016 Sep 06; 630:203-208.
    View in: PubMed
    Score: 0.089
  4. Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors. Clin Cancer Res. 2014 Oct 15; 20(20):5290-301.
    View in: PubMed
    Score: 0.076
  5. IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival. Clin Cancer Res. 2012 Nov 15; 18(22):6110-21.
    View in: PubMed
    Score: 0.068
  6. The expression of BST2 in human and experimental mouse brain tumors. Exp Mol Pathol. 2011 Aug; 91(1):440-6.
    View in: PubMed
    Score: 0.062
  7. NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma. J Immunother Cancer. 2024 Aug 30; 12(8).
    View in: PubMed
    Score: 0.039
  8. Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma. Cancer Immunol Res. 2022 06 03; 10(6):770-784.
    View in: PubMed
    Score: 0.033
  9. Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug. Cell Rep. 2021 11 02; 37(5):109957.
    View in: PubMed
    Score: 0.032
  10. Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation. Commun Biol. 2021 07 22; 4(1):905.
    View in: PubMed
    Score: 0.031
  11. Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC+ tumors respond to PD1/PD-L1 blockade therapy. J Immunother Cancer. 2019 08 26; 7(1):223.
    View in: PubMed
    Score: 0.028
  12. Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival. Clin Cancer Res. 2017 Nov 01; 23(21):6650-6660.
    View in: PubMed
    Score: 0.024
  13. Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma. Cancer Gene Ther. 2014 Jan; 21(1):38-44.
    View in: PubMed
    Score: 0.019
  14. Heme oxygenase-1 protects regulatory T cells from hypoxia-induced cellular stress in an experimental mouse brain tumor model. J Neuroimmunol. 2014 Jan 15; 266(1-2):33-42.
    View in: PubMed
    Score: 0.018
  15. Nanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapy. Small. 2013 Dec 20; 9(24):4123-9.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.